Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 24, 2012Diabetic Medicine

Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin

View Full Paper
Ask AI
Bookmark
Share

Authors

BBBetina T. BlakAstraZeneca (United Kingdom)HSHelen T. SmithHealth Economics and Outcomes Research (United Kingdom)MHMichelle Hards

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Blak et al. (2012) studied this question.

synapsesocial.com/papers/6a6fefa95d37378ac1dcfc84https://doi.org/10.1111/j.1464-5491.2012.03586.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*2009 · 47 citations
  2. 2Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial2008 · 150 citations
  3. 3The Treat-to-Target Trial2003 · 1,482 citations
  4. 4Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study2007 · 232 citations
  5. 5Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy2008 · 3,847 citations